Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
DentsplyXRAY |
$13M |
 |
Align TechnologyALGN |
-$137M |
 |
NovoCureNVCR |
-$124M |
 |
iRhythm TechnologiesIRTC |
-$608M |
 |
LeMaitre VascularLMAT |
-$3.96B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Nassif Mikheal | Jan 16, 2026 | Buy | 137 | $9.3349 | $1,300 |
| Nassif Mikheal | Nov 3, 2025 | Buy | 177 | $6.25 | $1,100 |
| Gupta Aashima | May 12, 2025 | Buy | 16,000 | $6.2492 | $100,000 |
| Woteki Catherine E | Apr 25, 2025 | Buy | 5,770 | $5.17 | $30,000 |
| BOREL JAMES C | Apr 24, 2025 | Buy | 30,000 | $4.99 | $150,000 |
| BOEHM WILLIAM T | Apr 24, 2025 | Buy | 5,000 | $5.235 | $26,000 |
| BOREL JAMES C | Apr 24, 2025 | Buy | 35,000 | $4.894 | $170,000 |
| Rocklin Amy M | Apr 23, 2025 | Buy | 12,500 | $4.99 | $62,000 |
| RODRIGUEZ RAFAEL A | Apr 22, 2025 | Buy | 7,474 | $4.59 | $34,000 |
| CAPELLO JEFFREY D | Apr 22, 2025 | Buy | 20,712 | $4.8386 | $100,000 |
| Tobin James P | Apr 22, 2025 | Buy | 10,000 | $4.7268 | $47,000 |
| Moylan John Patrick | Apr 10, 2025 | Buy | 10,000 | $5.07 | $51,000 |
| Naemura David H. | Jan 16, 2025 | Buy | 14,800 | $11.11 | $160,000 |
| ADENT JOHN EDWARD | Jan 16, 2025 | Buy | 23,035 | $11.03 | $250,000 |
| ADENT JOHN EDWARD | Oct 11, 2024 | Buy | 14,500 | $13.8 | $200,000 |
| Tobin James P | Aug 6, 2024 | Buy | 3,000 | $16.857 | $51,000 |
| Jones Douglas Edward | Apr 17, 2024 | Buy | 10,000 | $12.359 | $120,000 |
| BOREL JAMES C | Apr 11, 2024 | Buy | 7,500 | $13.0648 | $98,000 |
| ADENT JOHN EDWARD | Apr 10, 2024 | Buy | 23,000 | $12.3561 | $280,000 |
| Naemura David H. | Apr 10, 2024 | Buy | 12,500 | $12.5057 | $160,000 |
FAQ - Insider Transactions
The most recent insider transaction for Neogen was conducted by Nassif Mikheal, who sold 137 shares on January 16, 2026 at a price of $9.33 per share.
ADENT JOHN EDWARD has bought the most NEOG stock in the last 2 years, with a total value of $740,000.
According to our estimates, the total value of insider transactions for Neogen in the last 2 years is positive, amounting to $2.1M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
Over the last 2 years, insider transactions for Neogen have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
